Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-21 Sale | 2024-02-22 4:32 pm | Voyager Therapeutics Inc. | VYGR | PFREUNDSCHUH PETER P. Chief Financial Officer | 3,764 | $7.46 | $28,079 | 175,669 (Direct) | View |
| 2023-10-03 Sale | 2023-10-05 4:41 pm | Voyager Therapeutics Inc. | VYGR | PFREUNDSCHUH PETER P. Chief Financial Officer | 13,567 | $6.99 | $94,833 | 149,433 (Direct) | View |
| 2022-02-18 Sale | 2022-02-23 4:38 pm | Frequency Therapeutics Inc. | FREQ | PFREUNDSCHUH PETER P. Chief Financial Officer | 2,946 | $3.6948 | $10,885 | 8,927 (Direct) | View |
| 2022-02-16 Sale | 2022-02-18 4:14 pm | Frequency Therapeutics Inc. | FREQ | PFREUNDSCHUH PETER P. Chief Financial Officer | 2,525 | $4.3115 | $10,886 | 161,873 (Direct) | View |
| 2022-02-15 Sale | 2022-02-16 4:59 pm | Frequency Therapeutics Inc. | FREQ | PFREUNDSCHUH PETER P. Chief Financial Officer | 1,347 | $4.331 | $5,834 | 29,398 (Direct) | View |
| 2020-10-15 Sale | 2020-10-16 3:41 pm | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. Chief Financial Officer | 2,400 | $21.77 | $52,248 | 18,154 (Direct) | View |
| 2020-09-01 Sale | 2020-09-01 2:37 pm | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. Chief Financial Officer | 509 | $22.82 | $11,615 | 12,054 (Direct) | View |
| 2020-07-27 Sale | 2020-07-28 5:34 pm | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. Chief Financial Officer | 141 | $23.51 | $3,315 | 9,855 (Direct) | View |
| 2020-05-20 Sale | 2020-05-20 4:44 pm | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. Chief Financial Officer | 358 | $25.07 | $8,975 | 12,287 (Direct) | View |
| 2020-04-27 Sale | 2020-04-28 1:51 pm | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. Chief Financial Officer | 141 | $24.35 | $3,433 | 9,313 (Direct) | View |
| 2020-02-20 Sale | 2020-02-24 4:53 pm | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. Chief Financial Officer | 360 | $29.68 | $10,685 | 12,369 (Direct) | View |
| 2020-01-27 Sale | 2020-01-28 5:15 pm | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. Chief Financial Officer | 667 | $29.28 | $19,530 | 7,772 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-07-12 Option Award | 2024-07-12 5:29 pm | N/A 2034-07-12 | Y-mAbs Therapeutics Inc. | YMAB | PFREUNDSCHUH PETER P. CFO and Treasurer | 216,000 | $0 | 216,000 (Direct) | View |
| 2024-02-09 Option Award | 2024-02-16 4:58 pm | N/A 2034-02-09 | Voyager Therapeutics Inc. | VYGR | PFREUNDSCHUH PETER P. Chief Financial Officer | 90,000 | $0 | 239,433 (Direct) | View |
| 2023-02-17 Option Award | 2023-02-22 8:55 pm | N/A 2033-02-17 | Voyager Therapeutics Inc. | VYGR | PFREUNDSCHUH PETER P. Chief Financial Officer | 114,000 | $0 | 239,000 (Direct) | View |
| 2022-10-01 Option Award | 2022-10-04 4:15 pm | N/A N/A | Voyager Therapeutics Inc. | VYGR | PFREUNDSCHUH PETER P. Chief Financial Officer | 125,000 | $0 | 125,000 (Direct) | View |
| 2022-09-19 Option Award | 2022-09-21 4:41 pm | N/A 2032-09-19 | Voyager Therapeutics Inc. | VYGR | PFREUNDSCHUH PETER P. Chief Financial Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2022-02-17 Option Award | 2022-02-18 4:14 pm | N/A N/A | Frequency Therapeutics Inc. | FREQ | PFREUNDSCHUH PETER P. Chief Financial Officer | 150,000 | $0 | 161,873 (Direct) | View |
| 2022-02-14 Exercise | 2022-02-16 4:59 pm | N/A N/A | Frequency Therapeutics Inc. | FREQ | PFREUNDSCHUH PETER P. Chief Financial Officer | 15,000 | $0 | 29,398 (Direct) | View |
| 2021-04-20 Option Award | 2021-04-22 4:22 pm | N/A N/A | Frequency Therapeutics Inc. | FREQ | PFREUNDSCHUH PETER P. Chief Financial Officer | 30,000 | $0 | 30,000 (Direct) | View |
| 2021-01-15 Option Award | 2021-01-19 4:48 pm | N/A 2031-01-14 | Frequency Therapeutics Inc. | FREQ | PFREUNDSCHUH PETER P. Chief Financial Officer | 10,000 | $0 | 10,000 (Direct) | View |
| 2020-12-02 Option Award | 2020-12-03 5:44 pm | N/A 2030-12-01 | Frequency Therapeutics Inc. | FREQ | PFREUNDSCHUH PETER P. Chief Financial Officer | 230,000 | $0 | 230,000 (Direct) | View |
| 2020-10-15 Exercise | 2020-10-16 3:41 pm | N/A N/A | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. Chief Financial Officer | 9,834 | $0 | 18,154 (Direct) | View |
| 2020-09-01 Exercise | 2020-09-01 2:37 pm | N/A N/A | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. Chief Financial Officer | 1,042 | $0 | 12,054 (Direct) | View |
| 2020-07-26 Exercise | 2020-07-28 5:34 pm | N/A N/A | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. Chief Financial Officer | 417 | $0 | 9,855 (Direct) | View |
| 2020-05-20 Exercise | 2020-05-20 4:44 pm | N/A N/A | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. Chief Financial Officer | 1,041 | $0 | 12,287 (Direct) | View |
| 2020-04-26 Exercise | 2020-04-28 1:51 pm | N/A N/A | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. Chief Financial Officer | 417 | $0 | 9,313 (Direct) | View |
| 2020-02-20 Exercise | 2020-02-24 4:53 pm | N/A N/A | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. Chief Financial Officer | 1,042 | $0 | 12,369 (Direct) | View |
| 2020-01-31 Option Award | 2020-02-04 12:40 pm | N/A N/A | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. Chief Financial Officer | 21,000 | $0 | 21,000 (Direct) | View |
| 2020-01-26 Exercise | 2020-01-28 5:15 pm | N/A N/A | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. Chief Financial Officer | 1,666 | $0 | 7,772 (Direct) | View |